Carnegie Mellon University
81
7
12
58
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
9.9%
8 terminated/withdrawn out of 81 trials
87.9%
+1.4% vs industry average
0%
0 trials in Phase 3/4
31%
18 of 58 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (81)
Development of Adaptive Deep Brain Stimulation for OCD
Role: collaborator
Development of Adaptive Deep Brain Stimulation for OCD (Phase 1a)
Role: collaborator
Don't Throw Your Heart Away: Layperson Study 1
Role: lead
Don't Throw Your Heart Away: Medical Student Study 2
Role: lead
Don't Throw Your Heart Away: Clinician Study 3
Role: lead
Cognitive Training for Student Sleep and Wellness
Role: lead
Examining the Health Effects of NPOWER365 Among Black Same Gender Loving Men
Role: collaborator
Feasibility of Resting Intervals During Exercise Programs for Individuals With Knee Osteoarthritis
Role: collaborator
Transcranial Electrical Stimulation for Noninvasive Study of Menopausal/Perimenopausal Symptoms
Role: lead
Hydroxyurea and EPO in Sickle Cell Disease
Role: collaborator
Electrophysiological Source Imaging Guided Transcranial Focused Ultrasound
Role: lead
Evaluating FDA's Proposed Patient Medication Information Handout
Role: lead
Cortical Recording and Stimulating Array Brain-Machine Interface
Role: collaborator
Writing Interventions in Breast Cancer Patients Taking Aromatase Inhibitors
Role: lead
Flexible Representation of Speech
Role: collaborator
Phase II Adaptive Deep Brain Stimulation for Obsessive-Compulsive Disorder
Role: collaborator
Drinking in Young Adult Duos (DYAD) Study
Role: lead
Pilot Brief Communal Coping Intervention for Adults With Type 2 Diabetes
Role: lead
Pilot Brief Communal Coping Intervention for Adults With Type 1 Diabetes
Role: lead
Smartphone Training for Attention Regulation for IBS
Role: lead